Аннотация:
The paper provides an overview of current global approaches to pharmacotherapy for chronic recurrent cystitis, including non-antibacterial treatments. The urgency of this problem is associated with the extremely high prevalence of the disease in Russia and worldwide. The antimicrobial resistance in uropathogens has increased dramatically over the past two decades. In cases of recurrent cystitis, the routine management tactics for patients is to increase the time of, doses or to expand antibiotic therapy regimens, despite the lack of evidence supporting this treatment strategy. The lowest resistance of E. coli, the main pathogen of urinary tract infections, is noted for fosfomycin (0-2.9[%]), nitrofurans (0-4.4[%]) and mecillinam (0-4[%]). © 2019 Bionika Media Ltd.. All rights reserved.
Ключевые слова:
Antibiotic resistance; Chronic cystitis; D-mannose; Fosfomycin
fosfomycin; mecillinam; nitrofuran derivative; antibiotic resistance; antibiotic therapy; Article; chronic disease; chronic recurrent cystitis; cystitis; disease association; drug therapy; Escherichia coli; human; nonhuman; prevalence; Russian Federation; urinary tract infection
Ших Е. В. Евгения Валерьевна 1962-
Лазарева Н. Б. Наталья Борисовна 1978-
Реброва Е. В. Екатерина Владиславовна 1987-
Рязанова А. Y. У.
Shikh E. V. Evgeniya Valeryevna 1962-
Lazareva N. B. Natal`ya Borisovna 1978-
Rebrova E. V. Ekaterina Vladislavovna 1987-
Ryazanova A. Y. U.
Modern pharmacotherapy for chronic recurrent cystitis: Problems and opportunities [СОВРЕМЕННАЯ ФАРМАКОТЕРАПИЯ ХРОНИЧЕСКИХ РЕЦИДИВИРУЮЩИХ ЦИСТИТОВ: ПРОБЛЕМЫ И ВОЗМОЖНОСТИ]
Modern pharmacotherapy for chronic recurrent cystitis: Problems and opportunities [СОВРЕМЕННАЯ ФАРМАКОТЕРАПИЯ ХРОНИЧЕСКИХ РЕЦИДИВИРУЮЩИХ ЦИСТИТОВ:...
Текст визуальный непосредственный
Акушерство и гинекология
Бионика Медиа
Т. 2019, Вып. 7 С. 124-130
2019
Статья
Antibiotic resistance Chronic cystitis D-mannose Fosfomycin
fosfomycin mecillinam nitrofuran derivative antibiotic resistance antibiotic therapy Article chronic disease chronic recurrent cystitis cystitis disease association drug therapy Escherichia coli human nonhuman prevalence Russian Federation urinary tract infection
The paper provides an overview of current global approaches to pharmacotherapy for chronic recurrent cystitis, including non-antibacterial treatments. The urgency of this problem is associated with the extremely high prevalence of the disease in Russia and worldwide. The antimicrobial resistance in uropathogens has increased dramatically over the past two decades. In cases of recurrent cystitis, the routine management tactics for patients is to increase the time of, doses or to expand antibiotic therapy regimens, despite the lack of evidence supporting this treatment strategy. The lowest resistance of E. coli, the main pathogen of urinary tract infections, is noted for fosfomycin (0-2.9[%]), nitrofurans (0-4.4[%]) and mecillinam (0-4[%]). © 2019 Bionika Media Ltd.. All rights reserved.